Francisco Ricart
Psychiatry · Miami, FLNPI 1205905171
Payments from drug & device makers
Across 721 payments — averaging $3542.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$967K
- Eisai Inc.$621K
- E.r. Squibb & Sons, L.L.C.$380K
- Boehringer Ingelheim International GmbH$312K
- Avanir Pharmaceuticals, Inc.$151K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$75K
- plus $48K from 18 others
Across 7 payments — averaging $206.32 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Otsuka Pharmaceutical Development & Commercialization, Inc.$1K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 34 | $967,097 |
| Eisai Inc. | 237 | $620,850 |
| E.r. Squibb & Sons, L.L.C. | 25 | $379,766 |
| Boehringer Ingelheim International GmbH | 71 | $311,892 |
| Avanir Pharmaceuticals, Inc. | 16 | $151,404 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 4 | $74,839 |
| Otsuka America Pharmaceutical, Inc. | 74 | $24,594 |
| Boehringer Ingelheim RCV GmbH & Co KG | 21 | $13,546 |
| Johnson & Johnson(2 entities) | 8 | $5,493 |
| AbbVie(2 entities) | 81 | $1,408 |
| Takeda Pharmaceuticals U.S.A., Inc. | 45 | $882 |
| Vanda Pharmaceuticals Inc. | 20 | $435 |
| Sunovion Pharmaceuticals Inc. | 25 | $427 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 19 | $342 |
| Teva Pharmaceuticals USA, Inc. | 12 | $290 |
| Lundbeck LLC | 12 | $237 |
| Alkermes, Inc. | 8 | $168 |
| Neurocrine Biosciences, Inc. | 2 | $43 |
| Merck | 2 | $34 |
| Viiv Healthcare Company | 1 | $24 |
| Shire North American Group Inc | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| Idorsia Pharmaceuticals US Inc | 1 | $16 |
| Bausch Health US, LLC | 1 | $14 |
How this compares
$2,553,844 in reported general payments places this provider in the 95th percentile of 2,059 psychiatry providers in Florida.
Other psychiatry in Miami
- Silvia Silva-DulucMiami$11.7M
- Patricia JunqueraMiami$10.8M
- Evelio SosaMiami$6.9M
- Mario CuervoMiami$6.7M
- Emelina ArochaMiami$4.9M
- Maria RodilMiami$4.5M
- Marc AgroninMiami$4M
- Nancy Navarro-GonzalezMiami$2.6M
- Durim BozhdarajMiami$2.4M
- Carlos DangerMiami$2.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.